Search

for
Search:

Did you mean DPP-IV inhibitors?

GlossaryDipeptidyl Peptidase-4 Inhibitors (DPP-IV inhibitors)

block the enzyme DPP-4 to help regulate blood sugar

Dipeptidyl Peptidase-4 Inhibitors, often abbreviated as DPP-4 inhibitors, are a class of oral medications used to manage type 2 diabetes. They work by blocking the enzyme DPP-4, which results in increased levels of incretin hormones. These hormones help to regulate blood sugar by increasing insulin release and decreasing glucagon levels, particularly after meals.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 164 results

research Repurposing of Linagliptin and Similar FDA Approved Drugs as Antidiabetic Agents

May 2021 in “Letters in Applied NanoBioScience”

Pranlukast and mirabegron may work as new diabetes drugs.

research Cardiovascular Profile of Pharmacological Agents Used for the Management of Polycystic Ovary Syndrome

4 citations , January 2019 in “Therapeutic Advances in Endocrinology and Metabolism”

Medications for PCOS don't seem to raise heart disease risk.

research The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites

19 citations , July 2018 in “Medicines”

Juniperus plants contain compounds with potential for developing various medical treatments.

research Sequence-Structure Based Phylogeny of GPCR Class A Rhodopsin Receptors

57 citations , May 2014 in “Molecular Phylogenetics and Evolution”

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

research Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering

14 citations , May 2021 in “Marine Drugs”

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

View more "dpp-iv inhibitor" in research →

Community Join

0 / 0 results

— no results